Apogee Therapeutics Soars, Synopsys Gains, Norwegian Cruise Rises on Decline in Cost of Oil

Stock Movers

On this episode of Stock Movers:

- Apogee Therapeutics (APGE) soars after the drug developer provided maintenance data from a mid-stage trial that showed its experimental therapy deepened responses in patients with moderate-to-severe atopic dermatitis.

- Synopsys (SNPS) shares gain following reports that activist investor Elliott Investment Management has made a multibillion-dollar investment in the chip-design software company.

- Norwegian Cruise (NCLH) shares rose. Cruise companies traded higher in response to a decline in the cost of oil.

See omnystudio.com/listener for privacy information.

More description

On this episode of Stock Movers:

- Apogee Therapeutics (APGE) soars after the drug developer provided maintenance data from a mid-stage trial that showed its experimental therapy deepened responses in patients with moderate-to-severe atopic dermatitis.

- Synopsys (SNPS) shares gain following reports that activist investor Elliott Investment Management has made a multibillion-dollar investment in the chip-design software company.

- Norwegian Cruise (NCLH) shares rose. Cruise companies traded higher in response to a decline in the cost of oil.

See omnystudio.com/listener for privacy information.

2026-03-23 2 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.